Raysa Morales-Demori MD, FAAP
- Texas Medical Center
Assistant Professor of Pediatrics, Section of Critical Care Medicine
Baylor College of Medicine
|Universidad Central de Venezuela – Escuela de Medicina Luis Razetti||medical school||Doctor of Medicine||2008|
|Children’s Hospital of the University of Illinois – College of Medicine||residency||Pediatrics||2014|
|Baylor College of Medicine||fellowship||Pediatric Cardiology||2017|
|Baylor College of Medicine||fellowship||Pediatric Critical Care||2019|
The journey that a patient with congenital or acquired heart disease takes is complex and unique. I am humbled to share that journey with you by providing safe and high-quality care. I believe that family/primary care takers play a key role in patient’s clinical progress, for that reason, I make sure that each family understands their child’s condition and listen to care taker’s input.
My clinical interest in the management of pulmonary hypertension and/or right ventricular failure in patients with congenital heart disease.
Pulmonary hypertension; Pediatric Heart failure, Population studies in pediatric cardiology
|American Academy of Pediatrics||Member|
|American Academy of Pediatrics Member Society of Critical Care Medicine||Member|
|Pediatric Cardiac Intensive Care Society||Member|
Morales-Demori R. “Congenital heart disease and cardiac procedural outcomes in patients with trisomy 21 and Turner syndrome”. Congenit Heart Dis 2017 Dec;12(6):820-7.
Morales-Demori R, Jamil O, Serratto M. “Trend of Endurance Level Among Healthy Inner-City Children and Adolescents Over Three Decades”. Pediatric Cardiology 2017 Jan;38(1):123-7.
Rangel, MO., Morales Demori, R., Voll, ST., Wassouf, M., Dick, R., Doukky, R. "Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials". J Nucl Cardiol 2015, Oct; 5(22):1008-18.
Ballany, W., Mansour, K., Morales Demori, R., Al-Amoodi, M., Doukky, R. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: A substudy of the ASSUAGE trial. J Nucl Cardiol 2014, Jun; 21(3):496-502.
Doukky, R., Rangel, MO., Wassouf, M., Dick, R., Alqaid, A., Morales Demori, R. The Safety and Tolerability of Regadenoson in Patients with End-Stage Renal Disease: The First Prospective Evaluation. Journal of Nuclear Cardiology 2013 Apr;20(2):205-13.
Rangel, MO., Morales Demori, R., Doukky, R. Age and Gender as Predictors of Benefit From Aminophylline Administration in Patients Undergoing Regadenoson Stress Myocardial Perfusion Imaging: A Substudy of the ASSUAGE Trial. Am J Ther 2013. Nov-Dec;20(6):622-9.
Doukky, R., Morales Demori, R., Jain, S., Kiriakos, R., Mwansa, V., Calvin, JE. Attenuation of The Side Effect Profile of Regadenoson: A Randomized Double-Blind Placebo-Controlled Study with Aminophylline in Patients Undergoing Myocardial Perfusion Imaging. “THE ASSUAGE TRIAL". Journal of Nuclear Cardiology. 2012 Jun; 19(3):448-57.